Vaccine advisers to the Food
and Drug Administration are set to meet April 6 to discuss the possible need for more COVID-19
vaccine booster shots in the future.
The goal is to look at the
process for selecting variant specific boosters, and if the COVID-19 shot
schedule should mimic the flu shot.
No official vote is planned.
There will be no discussion of any specific products applying for authorization
or approval.